bearish
SinoMab (中国抗体) Post-IPO Trading: Decent Retail Interests Can't Save the Day
370 Views12 Nov 2019 11:05
SinoMab's IPO was priced at the low end and started trading today. We have highlighted in our earlier note that 1) the company's core product...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 2-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- SinoMab (中国抗体) Post-IPO Trading: Decent Retail Interests Can't Save the Day12 Nov 2019
- SinoMab (中国抗体) IPO - A Hard Sell30 Oct 2019
- SinoMab (中国抗体): Pipeline Concentrated on Autoimmune Therapy19 Jul 2019
x